PHENOTYPICALLY AND FUNCTIONALLY DISTINCT T-CELL SUBSETS IN ANTITUMOR RESPONSES

被引:46
作者
HAMAOKA, T
FUJIWARA, H
机构
来源
IMMUNOLOGY TODAY | 1987年 / 8卷 / 09期
关键词
D O I
10.1016/0167-5699(87)90186-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:267 / 269
页数:3
相关论文
共 30 条
[11]  
FUKUZAWA M, 1985, TRANSPLANT P, V17, P599
[12]   ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY CHEMO-IMMUNOTHERAPY WITH CYCLOPHOSPHAMIDE AND ADOPTIVELY TRANSFERRED IMMUNE SYNGENEIC LYMPHOCYTES-LYT-1+2- [J].
GREENBERG, PD ;
CHEEVER, MA ;
FEFER, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) :952-963
[13]   THERAPY OF DISSEMINATED MURINE LEUKEMIA WITH CYCLOPHOSPHAMIDE AND IMMUNE LYT-1+,2- T-CELLS - TUMOR-ERADICATION DOES NOT REQUIRE PARTICIPATION OF CYTO-TOXIC T-CELLS [J].
GREENBERG, PD ;
KERN, DE ;
CHEEVER, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1122-1134
[14]  
GREENBERG PD, 1987, IN PRESS CELLULAR IM
[15]  
Herberman R B, 1980, Contemp Top Immunobiol, V10, P61
[16]   A REEXAMINATION OF THE ROLE OF LYT-2-POSITIVE T-CELLS IN MURINE SKIN-GRAFT REJECTION [J].
LEFRANCOIS, L ;
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) :57-67
[17]  
LEVELAND BE, 1981, J EXP MED, V153, P1044
[18]  
LOWRY RP, 1983, TRANSPL P, V15, P343
[19]   EFFECTOR MECHANISMS IN ALLOGRAFT-REJECTION [J].
MASON, DW ;
MORRIS, PJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1986, 4 :119-145